Mannatech (NASDAQ:MTEX) Share Price Passes Below 200 Day Moving Average – Here’s What Happened

Mannatech, Incorporated (NASDAQ:MTEX) shares crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $6.08 and traded as low as $4.37. Mannatech shares last traded at $4.58, with a volume of 11,133 shares traded.

Wall Street Analyst Weigh In

Separately, Weiss Ratings lowered shares of Mannatech from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Mannatech presently has an average rating of “Sell”.

Mannatech Stock Performance

The company has a fifty day moving average of $5.09 and a two-hundred day moving average of $6.08. The firm has a market capitalization of $8.84 million, a price-to-earnings ratio of -0.68 and a beta of 0.72.

Mannatech (NASDAQ:MTEX) last released its earnings results on Thursday, May 14th. The company reported $0.49 earnings per share for the quarter. Mannatech had a negative return on equity of 2,383.34% and a negative net margin of 11.97%.The firm had revenue of $24.92 million during the quarter.

Insider Buying and Selling

In other Mannatech news, Director Kevin Andrew Robbins bought 7,100 shares of the business’s stock in a transaction on Tuesday, May 19th. The stock was purchased at an average cost of $4.17 per share, for a total transaction of $29,607.00. Following the completion of the purchase, the director directly owned 33,333 shares of the company’s stock, valued at approximately $138,998.61. This trade represents a 27.07% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Insiders have purchased 14,903 shares of company stock worth $62,155 in the last three months. 47.50% of the stock is owned by insiders.

Mannatech Company Profile

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.